XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 1,086 $ 95,691,194 $ (371,386) $ (39,282,870) $ 56,038,024
Balance, shares at Dec. 31, 2022 10,857,040        
Stock-based compensation 333,530 333,530
Net loss (3,867,765) (3,867,765)
Other comprehensive Income (loss) 71,709 71,709
Balance at Mar. 31, 2023 $ 1,086 96,024,724 (299,677) (43,150,635) 52,575,498
Balance, shares at Mar. 31, 2023 10,857,040        
Balance at Dec. 31, 2022 $ 1,086 95,691,194 (371,386) (39,282,870) 56,038,024
Balance, shares at Dec. 31, 2022 10,857,040        
Net loss           (11,775,613)
Other comprehensive Income (loss)           232,594
Balance at Sep. 30, 2023 $ 1,087 96,607,868 (138,792) (51,058,483) 45,411,680
Balance, shares at Sep. 30, 2023 10,869,040        
Balance at Mar. 31, 2023 $ 1,086 96,024,724 (299,677) (43,150,635) 52,575,498
Balance, shares at Mar. 31, 2023 10,857,040        
Stock-based compensation 392,390 392,390
Net loss (4,746,398) (4,746,398)
Other comprehensive Income (loss) 37,840 37,840
Issuance of restricted common stock awards $ 1 (1)
Issuance of restricted common stock awards, shares   12,000        
Balance at Jun. 30, 2023 $ 1,087 96,417,113 (261,837) (47,897,033) 48,259,330
Balance, shares at Jun. 30, 2023 10,869,040        
Stock-based compensation 190,755 190,755
Net loss (3,161,450) (3,161,450)
Other comprehensive Income (loss) 123,045 123,045
Balance at Sep. 30, 2023 $ 1,087 96,607,868 (138,792) (51,058,483) 45,411,680
Balance, shares at Sep. 30, 2023 10,869,040        
Balance at Dec. 31, 2023 $ 1,072 96,258,726 (107,460) (55,244,404) 40,907,934
Balance, shares at Dec. 31, 2023 10,721,192        
Stock-based compensation 134,057 134,057
Net loss (5,440,810) (5,440,810)
Other comprehensive Income (loss) 109,320 109,320
Common stock issued from warrant exercises $ 4 54,712 54,716
Common stock issued from warrant exercise, shares   37,613        
Balance at Mar. 31, 2024 $ 1,076 96,447,495 1,860 (60,685,214) 35,765,217
Balance, shares at Mar. 31, 2024 10,758,805        
Balance at Dec. 31, 2023 $ 1,072 96,258,726 (107,460) (55,244,404) 40,907,934
Balance, shares at Dec. 31, 2023 10,721,192        
Net loss           (14,906,013)
Other comprehensive Income (loss)           82,196
Balance at Sep. 30, 2024 $ 1,078 96,772,824 (25,264) (70,150,417) 26,598,221
Balance, shares at Sep. 30, 2024 10,784,725        
Balance at Mar. 31, 2024 $ 1,076 96,447,495 1,860 (60,685,214) 35,765,217
Balance, shares at Mar. 31, 2024 10,758,805        
Stock-based compensation 134,171 134,171
Net loss (4,959,506) (4,959,506)
Other comprehensive Income (loss) (8,445) (8,445)
Balance at Jun. 30, 2024 $ 1,076 96,581,666 (6,585) (65,644,720) 30,931,437
Balance, shares at Jun. 30, 2024 10,758,805        
Stock-based compensation 179,166 179,166
Net loss (4,505,697) (4,505,697)
Other comprehensive Income (loss) (18,679) (18,679)
Issuance of restricted common stock awards $ 2 (2)
Issuance of restricted common stock awards, shares   20,000        
Common stock issued from warrant exercises 11,994 11,994
Common stock issued from warrant exercise, shares   5,920        
Balance at Sep. 30, 2024 $ 1,078 $ 96,772,824 $ (25,264) $ (70,150,417) $ 26,598,221
Balance, shares at Sep. 30, 2024 10,784,725